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nosed by the elevation of cardiac biomarkers (plasma creatine kinase-
MB and cardiac troponin-T) above the 99th percentile of the upper
limit of the normal range with ST-segment elevation N0.1 mV in at
least one standard or two precordial leads. We excluded 34 patients
with the history of MI, percutaneous coronary intervention or coronary
artery bypass grafting and 27 patients who had no information of atmo-ST elevation myocardial infarction
Atmospheric temperature
Body mass index
Metabolic disorderThere is signiﬁcant seasonality for ST-elevation myocardial infarc-
tion (MI) (STEMI), and the occurrence of STEMI is concentrated in win-
ter [1]. By contrast, high-temperatures were reported to be also
associated with STEMI occurrence [2]. Therefore, the relationship be-
tween ambient temperature and cardiovascular mortality is known to
be not linear, but V-shaped [3]. The exposure to cold-temperature gen-
erally increases heart rate, blood pressure, plasmaﬁbrinogen concentra-
tion, platelet viscosity and so on [4], leading to be STEMI triggers via
activated sympathetic nervous system and increased hemodynamic re-
sponse. Moreover, the changes in cholesterol concentrations are often
observed in summer or warmer environment [5], and have a possibility
to be STEMI triggers. Thus, the clinical characteristics might be different
between colder-season-onset and warmer-season-onset STEMI. In this
study, hence, we sought to clarify the clinical characteristics of high-
temperature-onset STEMI.
This studywas conducted atMiyazaki-Prefectural-NobeokaHospital
with 293 enrolled consecutive patients who were admitted due to
STEMI between April 2008 and March 2011. The areas of STEMI onsetascular Medicine, Kumamoto
jo, Chuo-ku, Kumamoto, Japan.
).
land Ltd. This is an open access articlwere fromacross the northMiyazaki-Prefecture, Japan. STEMIwas diag-
spheric temperatures at onset-time of STEMI. Finally, 232 STEMI pa-
tients were analyzed for a possible association with atmospheric
temperature. The information of atmospheric temperature at onset-
time of STEMI was obtained using hourly measurements by Nobeoka
local meteorological observatory or AutomatedMeteorological Data Ac-
quisition System. The median value of atmospheric temperature (17 °C
at onset-time of STEMI) was used to divide STEMI patients into low- or
high-temperature-onset groups. Increased body mass index (BMI) was
deﬁned as BMI ≥25 kg/m2. Renal impairment was deﬁned as estimated
glomerular ﬁltration rate b60mL/min/1.73 m2. Preserved left ventricu-
lar ejection fraction (LVEF) was deﬁned as LVEF ≥50% (LVEF was mea-
sured by echocardiography using the modiﬁed Simpson method).
The study protocol conformed to the principles of the Declaration of
Helsinki. Written informed consent was obtained from all of the pa-
tients. This study is registered at the University Hospital Medical Infor-
mation Network (UMIN) Clinical Trials Registry (UMIN 000015672).
The clinical characteristics of the low- and high-temperature-
onset STEMI groups were shown in Table 1a. BMI was signiﬁcantly
higher in the high-temperature-onset STEMI group than in the
low-temperature-onset STEMI group. In laboratory ﬁndings, HDL-
cholesterol and blood urea nitrogen (BUN)/creatinine ratio was sig-
niﬁcantly lower in high-temperature-onset STEMI group compared
to low-temperature-onset STEMI group. In angiographic ﬁndings,
the number of patients with left main trunk culprit lesions was sig-
niﬁcantly lower in high-temperature-onset STEMI group than in
low-temperature-onset STEMI group. However, there were no sig-
niﬁcant differences in prior medications, echocardiographic ﬁndings
and outcomes. Multivariate-logistic regression analysis showed thate under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1a
Comparison of clinical characteristics between high- and low-environmental temperature
onset STEMI groups.
Variables High-temperature-onset
STEMI group
(≥17 °C)
(n = 119)
Low-temperature-onset
STEMI group
(b17 °C)
(n = 113)
P-value
Baseline characteristics
Age, years 69.2 ± 12.4 71.4 ± 11.6 0.26
Male gender (%) 85 (71) 72 (64) 0.21
BMI, kg/m2 23.8 ± 3.2 22.7 ± 3.1 0.02
HT, n (%) 69 (58) 77 (68) 0.11
DM, n (%) 34 (29) 31 (27) 0.85
Dyslipidemia, n (%) 81 (68) 73 (65) 0.58
cSM, n (%) 43 (36) 40 (35) 0.91
Prior medications
Aspirin, n (%) 17 (14) 14 (13) 0.69
CCB, n (%) 32 (27) 42 (38) 0.08
ACE-I/ARB, n (%) 30 (25) 33 (29) 0.47
β-Blocker, n (%) 7 (6) 4 (4) 0.41
Statin, n (%) 12 (10) 10 (9) 0.76
Laboratory ﬁndings
Total cholesterol,
mg/dL
196.9 ± 42.1 200.4 ± 42.4 0.44
Triglyceride, mg/dL 139.3 ± 115.1 129.5 ± 112.2 0.13
HDL-cholesterol,
mg/dL
44.7 ± 11.6 48.2 ± 13.2 0.03
LDL-cholesterol,
mg/dL
125.3 ± 35.5 126.1 ± 35.1 0.77
Hematocrit, % 40.9 ± 5.2 40.1 ± 5.7 0.43
BUN/creatinine ratio 18.4 ± 7.1 20.2 ± 7.7 0.02
eGFR,
mL/min/1.73 m2
47.6 ± 17.8 50.2 ± 19.4 0.25
Peak CK-MB, ng/mL 212.7 ± 163.1 236.1 ± 206.9 0.79
CRP, mg/dL 0.797 ± 1.98 1.384 ± 3.76 0.14
Echocardiographic ﬁndings
Left ventricular EF, % 55.6 ± 10.4 55.4 ± 11.1 0.82
Aortic stenosis, n (%) 3 (3) 4 (4) 0.65
Mitral regurgitation,
n (%)
13 (12) 7 (7) 0.20
Angiographic ﬁndings
LMT lesion, n (%) 2 (2) 8 (7) 0.04
LAD lesion, n (%) 52 (44) 54 (48) 0.53
LCX lesion, n (%) 13 (11) 12 (11) 0.94
RCA lesion, n (%) 55 (46) 44 (39) 0.26
Multi-vessel disease,
n (%)
42 (35) 52 (46) 0.10
Outcomes
In hospital death,
n (%)
4 (3) 7 (6) 0.68
Cardiovascular
death, n (%)
4 (3) 5 (4) 0.67
Abbreviations: BMI, bodymass index; HT, hypertension; DM, diabetes mellitus; cSM, cur-
rent smoker; CCB, calcium-channel blocker; ACEI, angiotensin-converting enzyme inhibi-
tor; ARB, angiotensin II receptor blocker; BUN, blood urea nitrogen; eGFR, estimated
glomerularﬁltration rate; CK-MB, creatine kinase-MB;CRP, C-reactive protein; EF, ejection
fraction; LMT, left main trunk; LAD, left anterior descending; LCX, left circumﬂex artery;
and RCA, right coronary artery.
P-values were obtained by Mann–Whitney U tests and chi-squared tests.
Table 1b
Factors associated with high environmental temperature onset STEMI.
Univariate analysis Multivariate analysis
OR (95% CI) P-value OR (95% CI) P-value
Age (≥65 y) (+) 0.89 (0.52–1.54) 0.68 Not selected
Male gender (+) 1.43 (0.82–2.48) 0.21 Not selected
BMI (/1 kg/m2) 1.12 (1.02–1.22) 0.01 1.10 (1.01–1.20) 0.04
HT (+) 0.65 (0.38–1.11) 0.11 Not selected
DM (+) 1.06 (0.60–1.88) 0.85 Not selected
Dyslipidemia (+) 1.17 (0.68–2.02) 0.58 Not selected
cSM (+) 1.03 (0.60–1.77) 0.91 Not selected
Total-cholesterol
(/1 mg/dL)
1.00 (0.99–1.00) 0.53 Not selected
Triglyceride (/1 mg/dL) 1.00 (1.00–1.00) 0.52 Not selected
HDL-cholesterol
(/1 mg/dL)
0.98 (0.96–1.00) 0.04 0.98 (0.96–1.01) 0.17
LDL-cholesterol
(/1 mg/dL)
1.00 (0.99–1.01) 0.85 Not selected
BUN/creatinine ratio 0.97 (0.93–1.00) 0.06 Not selected
Hematocrit (/1%) 1.03 (0.98–1.08) 0.24 Not selected
LMT lesion (+) 0.22 (0.05–1.08) 0.06 Not selected
LAD lesion (+) 0.85 (0.51–1.42) 0.53 Not selected
Preserved LVEF (≥50%)
(+)
1.15 (0.64–2.05) 0.65 Not selected
Renal impairment (+) 0.93 (0.52–1.66) 0.81 Not selected
Aspirin (+) 1.17 (0.55–2.49) 0.69 Not selected
CCB (+) 0.61 (0.35–1.07) 0.08 Not selected
ACE-I/ARB (+) 0.81 (0.45–1.44) 0.47 Not selected
β-Blocker (+) 1.69 (0.48–5.92) 0.41 Not selected
Statin (+) 1.14 (0.47–2.76) 0.77 Not selected
Abbreviations: HT, hypertension; DM, diabetes mellitus; cSM, current smoker; LMT, left
main trunk; LAD, left anterior descending; LVEF, left ventricular ejection fraction; CCB, cal-
cium-channel blocker; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II
receptor blocker.
P-values were obtained using logistic regression analysis.
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temperature-onset STEMI (Table 1b). Next, to examine the differences in
distribution of STEMI, the patients were further divided into ﬁve groups
by their BMI according to Japan Society for the Study of Obesity guideline
(b18.5 kg/m2, 18.5–22 kg/m2, 22–25 kg/m2, 25–30 kg/m2, ≥30 kg/m2).
We found that the patients with BMI 25–30 kg/m2 were signiﬁcantly
higher in high-temperature-onset group than in low-temperature-onset
group (32% vs. 20%, P = 0.04, Fig. 1).
Obesity has been reported to be signiﬁcantly associated with life-
style related diseases such asmetabolic disorders, type 2 DMand hyper-
tension, leading to cardiovascular diseases [6]. Adipose tissues areendocrine organs that secrete various kinds of active molecules,
known as adipokines. So called “malignant adipokines” such as tumor
necrosis factor-α, interleukin (IL)-6 and IL-8 are well known pro-
inﬂammatory cytokines [7]. The accumulation of adipose tissue initiates
disturbances in adipokines, leading to both the overproduction of pro-
inﬂammatory adipokines and the reduction of anti-atherogenic
adipokines such as adiponectin. These phenomena further accelerate
the development of atherosclerotic properties and the occurrence of
cardiovascular events [8]. Thus, metabolic disorders are thought to be
one of the causes of inﬂammatory reactions.
The reduction of HDL-cholesterol is also associated with metabolic
disorder, leading to cardiovascular diseases [6,9]. Halonen et al. previ-
ously reported that HDL-cholesterol is decreased in high-temperature
environments, therefore the decreased HDL-cholesterol is known to
be one of the triggers of STEMI in high-temperature environment [5].
The present study demonstrated that increased BMI was signiﬁcantly
associated with high-temperature-onset STEMI and HDL-cholesterol
was signiﬁcantly lower in high-temperature-onset STEMI group, sug-
gesting that severe metabolic disorder might be a signiﬁcant risk factor
of high-temperature-onset STEMI.
Because high BMI subjects have signiﬁcant higher osmolality levels
than lean subjects [10], hemoconcentration is thought to be one of key
triggers for STEMI occurrence under high environmental temperature
conditions. In our study, however, hematocrit and BUN/creatinine ratios
were not signiﬁcantly higher in high-temperature-onset STEMI, indicat-
ing that hemoconcentration might not be a very important factor for
STEMI in high-temperature-onset STEMI in Japanese patients.
This study has several limitations. First, the results should be
interpreted with caution as the study was a retrospective and observa-
tional study. It is therefore difﬁcult to establish a clear cause–effect rela-
tionship. Second, patients' behavioral changes related to the outdoor
temperatures were not considered. In this study, the rate of STEMI oc-
currence outdoors was only 20%, so it is important to consider how
STEMI patients behave indoors in both low and high temperature
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Fig. 1. Distribution of the number of ST-elevation myocardial infarction patients according to body mass index in low-environmental-temperature onset group (a) and in high-
environmental-temperature onset group (b). Abbreviation: BMI, body mass index.
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was difﬁcult to obtain, an important limitation of this study. Third,
daily maximum or average temperature at the day of STEMI occurrence
was used to evaluate the association between ambient temperature and
cardiovascular mortality in previous most papers. In contrast, we divid-
ed STEMI patients into low- or high-temperature-onset STEMI groups
by using atmospheric temperature at onset-time of STEMI and found
that atmospheric temperature at onset-time might be important for
STEMI occurrence.
Despite these limitations, this study ﬁrstly demonstrated that the
presence of increased BMI was found to be signiﬁcantly associated
with STEMI occurrence in high-temperature environment. Metabolic
disorder might be a key risk factor for high-temperature-onset STEMI.
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